Thalamic infarcts in young adults: relationship between clinical-topographic features and pathogenesis.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMID 11803190)

Published in Eur Neurol on January 01, 2002

Authors

Alessandro Pezzini1, Elisabetta Del Zotto, Silvana Archetti, Alberto Albertini, Roberto Gasparotti, Mauro Magoni, Luigi Amedeo Vignolo, Alessandro Padovani

Author Affiliations

1: Department of Neurology, University of Brescia, Italy. ale_pezzini@hotmail.com

Articles by these authors

Functional atlas of emotional faces processing: a voxel-based meta-analysis of 105 functional magnetic resonance imaging studies. J Psychiatry Neurosci (2009) 4.16

Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol (2007) 3.25

Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. Stroke (2002) 2.79

Debunking 7 myths that hamper the realization of randomized controlled trials on intra-arterial thrombolysis for acute ischemic stroke. Stroke (2007) 2.57

Loss of sight and sound. Could it be the hip? Lancet (2009) 2.43

Italian multicenter experience with flow-diverter devices for intracranial unruptured aneurysm treatment with periprocedural complications--a retrospective data analysis. Neuroradiology (2012) 2.31

A transcriptional sketch of a primary human breast cancer by 454 deep sequencing. BMC Genomics (2009) 2.27

Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation (2004) 2.18

Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke (2007) 2.02

Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol (2005) 1.82

Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale. Stroke (2003) 1.81

Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain (2005) 1.73

Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis. J Bone Miner Res (2003) 1.55

A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats. Hum Mutat (2013) 1.53

Endothelial nitric oxide synthase (Glu298Asp) polymorphism is an independent risk factor for migraine with aura. Headache (2006) 1.52

Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med (2007) 1.48

Disulfiram neuropathy: two cases of distal axonopathy. Clin Toxicol (Phila) (2008) 1.47

Hyperhomocysteinemia: a potential risk factor for cervical artery dissection following chiropractic manipulation of the cervical spine. J Neurol (2002) 1.44

Evidence of white matter changes on diffusion tensor imaging in frontotemporal dementia. Arch Neurol (2007) 1.42

Outcomes of Alzheimer's disease treatment: the Italian CRONOS project. Int J Geriatr Psychiatry (2003) 1.40

Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis. Cell Transplant (2009) 1.36

Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease. Neurotox Res (2009) 1.35

Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration. Int J Geriatr Psychiatry (2007) 1.34

[alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol Med (2002) 1.26

Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. Mov Disord (2011) 1.25

Arginase pathway in human endothelial cells in pathophysiological conditions. J Mol Cell Cardiol (2004) 1.24

Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity. J Neurosci (2007) 1.23

Human mitochondrial ferritin expressed in HeLa cells incorporates iron and affects cellular iron metabolism. J Biol Chem (2002) 1.22

TCIRG1-dependent recessive osteopetrosis: mutation analysis, functional identification of the splicing defects, and in vitro rescue by U1 snRNA. Hum Mutat (2004) 1.21

Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors. Int J Geriatr Psychiatry (2007) 1.19

Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation. Clin Chem Lab Med (2002) 1.19

Identification of new mutations of the HFE, hepcidin, and transferrin receptor 2 genes by denaturing HPLC analysis of individuals with biochemical indications of iron overload. Clin Chem (2003) 1.15

Course and management of allogeneic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy. J Neurol (2012) 1.15

Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease. J Neurochem (2008) 1.15

Diffusion-weighted MR of the brain: methodology and clinical application. Radiol Med (2005) 1.14

The neuromelanin of human substantia nigra: physiological and pathogenic aspects. Pigment Cell Res (2004) 1.12

SMC1 involvement in fragile site expression. Hum Mol Genet (2005) 1.11

Cumulative effect of predisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke in young adults. Stroke (2005) 1.11

The surface oxidation potential of human neuromelanin reveals a spherical architecture with a pheomelanin core and a eumelanin surface. Proc Natl Acad Sci U S A (2006) 1.11

Reduction in retinal nerve fiber layer thickness in migraine patients. Neurol Sci (2012) 1.10

Atypical phenotypes and clinical variability in a large Italian family with DYT1-primary torsion dystonia. Mov Disord (2006) 1.08

Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment. Int J Geriatr Psychiatry (2006) 1.07

New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals. Proc Natl Acad Sci U S A (2008) 1.07

Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain (2005) 1.06

Pitfalls in diagnosing mitochondrial neurogastrointestinal encephalomyopathy. J Inherit Metab Dis (2011) 1.05

The role of mitochondria in neurodegenerative diseases. J Neurol (2011) 1.05

Neuropathology of mitochondrial diseases. Biosci Rep (2007) 1.05

QT dispersion and heart rate variability abnormalities in Alzheimer's disease and in mild cognitive impairment. J Am Geriatr Soc (2005) 1.04

Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes. Cell Transplant (2009) 1.04

Cerebral amyloid angiopathy-related hemorrhages. Neurol Sci (2008) 1.03

Association between tau H2 haplotype and age at onset in frontotemporal dementia. Arch Neurol (2005) 1.02

Evaluation of human gene variant detection in amplicon pools by the GS-FLX parallel Pyrosequencer. BMC Genomics (2008) 1.02

Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients. J Neuroinflammation (2011) 1.02

Epilepsy in glioblastoma multiforme: correlation with glutamine synthetase levels. J Neurooncol (2009) 1.02

Is frontotemporal lobar degeneration a rare disorder? Evidence from a preliminary study in Brescia county, Italy. J Alzheimers Dis (2010) 1.00

Blood cell markers in Alzheimer Disease: Amyloid Precursor Protein form ratio in platelets. Exp Gerontol (2009) 0.99

Differential impact of apathy and depression in the development of dementia in mild cognitive impairment patients. Dement Geriatr Cogn Disord (2009) 0.99

Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines. J Neurochem (2004) 0.99

White matter changes in corticobasal degeneration syndrome and correlation with limb apraxia. Arch Neurol (2008) 0.99

Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study. Cerebrovasc Dis (2010) 0.99

Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD. Neurobiol Aging (2011) 0.98

New MR sequences in daily practice: susceptibility weighted imaging. A pictorial essay. Insights Imaging (2011) 0.98

Small nerve fiber pathology in critical illness. PLoS One (2013) 0.97

Migraine and ischemic stroke: a debated question. J Cereb Blood Flow Metab (2008) 0.97

Amniotic membrane patching promotes ischemic rat heart repair. Cell Transplant (2009) 0.97

Subcortical and deep cortical atrophy in Frontotemporal Lobar Degeneration. Neurobiol Aging (2009) 0.97

Levels of beta-secretase BACE and alpha-secretase ADAM10 mRNAs in Alzheimer hippocampus. Neuroreport (2002) 0.96

Systemic thrombolysis in patients with acute ischemic stroke and Internal Carotid ARtery Occlusion: the ICARO study. Stroke (2011) 0.96

Homocysteine and cerebral ischemia: pathogenic and therapeutical implications. Curr Med Chem (2007) 0.95

Complete gene expression profiling of Saccharopolyspora erythraea using GeneChip DNA microarrays. Microb Cell Fact (2007) 0.94

Epilepsy in cerebral glioma: timing of appearance and histological correlations. J Neurooncol (2009) 0.94